503A compounding
A pharmacy designation for compounded medications prepared for individual patients. BPC-157 was removed from 503A eligibility in 2023.
Which Procedures Involve 503A compounding?
503A compounding appears in the following procedure guides on ProcedureFinder:
Frequently Asked Questions
What is 503A compounding? +
A pharmacy designation for compounded medications prepared for individual patients. BPC-157 was removed from 503A eligibility in 2023. On ProcedureFinder, 503A compounding appears in the BPC-157 Peptide Therapy cost guide. BPC-157 has been studied in over 100 published animal model papers, primarily from a single research group at the University of Zagreb.
How much does bpc-157 peptide therapy cost? +
BPC-157 Peptide Therapy costs $250 to $1,200 per month (when available); historical pricing 2022-2023 era nationally, with a median of $450 in ProcedureFinder's cash-pay benchmarks. A 15-amino-acid pentadecapeptide derived from a gastric protein, marketed for tendon, ligament, and gut healing. Currently restricted by FDA from 503A compounding.